FinTrust Capital Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$29K	Hold	2,000	–	–	﹤0.01%	720
2024 Q2	$17K	Hold	2,000	–	–	﹤0.01%	784
2024 Q1	$20.4K	Buy	+2,000	New	+$20.4K	﹤0.01%	713